Arundel Cherinne, Lam Phillip H, Khosla Rahul, Blackman Marc R, Fonarow Gregg C, Morgan Charity, Zeng Qing, Fletcher Ross D, Butler Javed, Wu Wen-Chih, Deedwania Prakash, Love Thomas E, White Michel, Aronow Wilbert S, Anker Stefan D, Allman Richard M, Ahmed Ali
Veterans Affairs Medical Center, Washington, DC.
Georgetown University Hospital/Washington Hospital Center, Washington, DC.
Am J Med. 2016 Nov;129(11):1178-1184. doi: 10.1016/j.amjmed.2016.06.018. Epub 2016 Jul 9.
Heart failure is the leading cause for 30-day all-cause readmission. We examined the impact of 30-day all-cause readmission on long-term outcomes and cost in a propensity score-matched study of hospitalized patients with heart failure.
Of the 7578 Medicare beneficiaries discharged with a primary diagnosis of heart failure from 106 Alabama hospitals (1998-2001) and alive at 30 days after discharge, 1519 had a 30-day all-cause readmission. Using propensity scores for 30-day all-cause readmission, we assembled a matched cohort of 1516 pairs of patients with and without a 30-day all-cause readmission, balanced on 34 baseline characteristics (mean age 75 years, 56% women, 24% African American).
During 2-12 months of follow-up after discharge from index hospitalization, all-cause mortality occurred in 41% and 27% of matched patients with and without a 30-day all-cause readmission, respectively (hazard ratio 1.68; 95% confidence interval 1.48-1.90; P <.001). This harmful association of 30-day all-cause readmission with mortality persisted during an average follow-up of 3.1 (maximum, 8.7) years (hazard ratio 1.33; 95% confidence interval 1.22-1.45; P <.001). Patients with a 30-day all-cause readmission had higher cumulative all-cause readmission (mean, 6.9 vs 5.1; P <.001), a longer cumulative length of stay (mean, 51 vs 43 days; P <.001), and a higher cumulative cost (mean, $38,972 vs $34,025; P = .001) during 8.7 years of follow-up.
Among Medicare beneficiaries hospitalized for heart failure, 30-day all-cause readmission was associated with a higher risk of subsequent all-cause mortality, higher number of cumulative all-cause readmission, longer cumulative length of stay, and higher cumulative cost.
心力衰竭是30天全因再入院的主要原因。我们在一项对心力衰竭住院患者进行倾向评分匹配的研究中,考察了30天全因再入院对长期预后和费用的影响。
在阿拉巴马州106家医院(1998 - 2001年)以心力衰竭为主要诊断出院的7578名医疗保险受益人中,出院后30天仍存活的患者有1519人发生了30天全因再入院。利用30天全因再入院的倾向评分,我们组建了一个匹配队列,其中有1516对患者,分别为有和没有30天全因再入院的患者,在34项基线特征上达到平衡(平均年龄75岁,56%为女性,24%为非裔美国人)。
在首次住院出院后的2 - 12个月随访期间,有和没有30天全因再入院的匹配患者中,全因死亡率分别为41%和27%(风险比1.68;95%置信区间1.48 - 1.90;P <.001)。在平均3.1年(最长8.7年)的随访期间,30天全因再入院与死亡率之间的这种有害关联持续存在(风险比1.33;95%置信区间1.22 - 1.45;P <.001)。在8.7年的随访期间,有30天全因再入院的患者有更高的累积全因再入院率(平均6.9次对5.1次;P <.001)、更长的累积住院时间(平均51天对43天;P <.001)以及更高的累积费用(平均38,972美元对34,025美元;P =.001)。
在因心力衰竭住院的医疗保险受益人中,30天全因再入院与随后更高的全因死亡风险、更高的累积全因再入院次数、更长的累积住院时间以及更高的累积费用相关。